Buchu (Agathosma betulina and A. crenulata, Rutaceae) essential oils: their pharmacological action on guinea-pig ileum and antimicrobial activity on microorganisms.
The mode of action of essential oils from two buchu species (Agathosma betulina and A. crenulata, Rutaceae) from the Cape region of South Africa has been studied on smooth muscle in-vitro using guinea-pig ileum. At high concentration, the oils had an initial spasmogenic activity followed by spasmolysis. The spasmolytic action was post-synaptic, not atropine-like and did not involve adrenoceptor or guanylyl cyclase activation. In the presence of the phosphodiesterase inhibitor rolipram, the spasmolytic action of A. betulina was significantly increased whilst that due to A. crenulata was also increased but not to a significant level. These results suggested a mode of action for the oils involving cyclic adenosine monophosphate. In addition, A. betulina appeared to block calcium channels but this was not seen with A. crenulata, possibly because the initial spasmogenic activity complicated the study of its spasmolytic action. Neither essential oil (10 microL, undiluted) demonstrated antimicrobial action against Enterococcus hirae and Pseudomonas aeruginosa but very low activity was observed against Escherichia coli, Saccharomyces cerevisiae and Staphylococcus aureus, suggesting little potential for these oils as antimicrobial agents/preservatives.
Lis-Balchin
M
M
School of Applied Science, South Bank University, London, UK. lisbalmt@sbu.ac.uk
Hart
S
S
Simpson
E
E
D000818:Animals; D015220:Calcium Channels / Q000187:drug effects; D046508:Culture Techniques; D000242:Cyclic AMP / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D016983:Enterococcus / Q000187:drug effects; D006168:Guinea Pigs; D007082:Ileum / Q000187:drug effects* / Q000502:physiology; D008826:Microbial Sensitivity Tests; D009119:Muscle Contraction; D009130:Muscle, Smooth / Q000187:drug effects* / Q000502:physiology; D009822:Oils, Volatile / Q000494:pharmacology*; D010938:Plant Oils / Q000494:pharmacology*; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D020889:Rolipram / Q000494:pharmacology; D012441:Saccharomyces cerevisiae / Q000187:drug effects; D013035:Spasm / Q000139:chemically induced; D013211:Staphylococcus aureus / Q000187:drug effects
D015220:Calcium Channels; D009822:Oils, Volatile; D010938:Plant Oils; D000242:Cyclic AMP; D020889:Rolipram